Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 9602203.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Severe forms of epidermolysis bullosa result in a transfusion-dependent chronic anemia and are fatal. The cause of the anemia is unknown. We evaluated five children whose anemia failed to respond to oral iron but who became transfusion independent after treatment with intravenous iron and human recombinant erythropoietin.
Medical subject headings
- Anemia, Refractory
- Epidermolysis Bullosa
- Erythropoietin
- Iron